| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | US20060171960 Methods and composition for oral vaccination |
| 08/03/2006 | US20060171958 Antiviral activity from medicinal mushrooms |
| 08/03/2006 | US20060171957 Polypeptide-vaccines for broad protetion against hypervirulent meningococcal lineages |
| 08/03/2006 | US20060171901 Treatment of malodour |
| 08/03/2006 | CA2599228A1 Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives |
| 08/03/2006 | CA2596131A1 Liposomal compositions for parenteral delivery of agents |
| 08/03/2006 | CA2595889A1 N-halogenated amino acids and n,n-dihalogenated amino acids in combination with hypohalous acids |
| 08/03/2006 | CA2594708A1 Chemical compounds |
| 08/03/2006 | CA2593801A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/03/2006 | CA2567789A1 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 08/02/2006 | EP1686113A1 Inhibitors of aspartyl protease |
| 08/02/2006 | EP1685836A2 Antifungal activity of dicationic molecules |
| 08/02/2006 | EP1685184A1 Tri-block copolymers and a process for the preparation of the same |
| 08/02/2006 | EP1685130A1 Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof |
| 08/02/2006 | EP1685127A1 Heterocyclyl-substituted oxetanes for the treatment of proliferative or infectious diseases |
| 08/02/2006 | EP1685123A2 Substituted dihydroquinazolines ii |
| 08/02/2006 | EP1684868A1 Treatment of hi-virus infections with oxidised blood proteins |
| 08/02/2006 | EP1684810A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 08/02/2006 | EP1684796A2 Methods for modulating the th2 immuneresponse to an antigen by adding or removing activated carbonyl groups from the antigen |
| 08/02/2006 | EP1684778A1 Herbal extracts of salicornia species, process of preparation thereof, use thereof against tuberculosis |
| 08/02/2006 | EP1684738A1 Inhibitors of yeast filamentous growth and method of their manufacture |
| 08/02/2006 | EP1440149B1 Use of an infectious and attenuated type ii bovine viral diarrhea virus clone to prevent foetal infection by type i bvdv |
| 08/02/2006 | EP1397154B1 Abin-mediated hepatitis protection |
| 08/02/2006 | EP1296656B1 Method for preparing a composition |
| 08/02/2006 | EP1274421B1 Use of MEK-inhibitors for producing a medicament to treat negativstrang-RNA-viruses infections |
| 08/02/2006 | EP1265598B1 Pharmaceutical composition for application to mucosal surfaces |
| 08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 08/02/2006 | EP1239791B1 Dental prosthesis with means for the release of active substances |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1143986B1 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| 08/02/2006 | EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 08/02/2006 | EP1017397B1 Photosensitizer conjugates for pathogen targeting |
| 08/02/2006 | EP0758249B1 Programmable genotoxic agents and uses therefor |
| 08/02/2006 | EP0751962B1 Methods for inhibiting cd14 mediated cell activation |
| 08/02/2006 | CN1813062A Bacteriophages bacteriolysin |
| 08/02/2006 | CN1812992A HIV integrase inhibitors |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812805A Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 08/02/2006 | CN1812775A Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol |
| 08/02/2006 | CN1810947A Garlic oil refining process and the prepn process of its emulsion and solid nanometer liposome particle |
| 08/02/2006 | CN1810839A Anti-hepatitis B virus fusion protein and its coding gene and application |
| 08/02/2006 | CN1810830A HIV-1 yesisting polypeptide C22, its coding sequence and prepn process |
| 08/02/2006 | CN1810823A Specific chicken CpG ODN and its application |
| 08/02/2006 | CN1810821A Industrial production process of palmitate of clindamycin hydrochloride |
| 08/02/2006 | CN1810816A Tenoforv monoester compounds with HIV-1/HBV virus copying inhibiting activity |
| 08/02/2006 | CN1810815A Nitroimidazole derivative for treatment |
| 08/02/2006 | CN1810794A Prepn process and medicine composition of dewatered andrographolide |
| 08/02/2006 | CN1810777A Compound for preventing and treating bacterial infection and its prepn and use |
| 08/02/2006 | CN1810759A Rheinic acid preparing process |
| 08/02/2006 | CN1810291A Nasal cavity spraying inactivated influenza virus vaccine and its prepn process |
| 08/02/2006 | CN1810280A Medicine composition for treating rheumatism, rheumatoidal diseases, etc. and its prepn process |
| 08/02/2006 | CN1810272A Prepn process of red sage prepn and its quality control method |
| 08/02/2006 | CN1810267A Puerariae Decoction mixture preparing process |
| 08/02/2006 | CN1810253A Composition of water soluble Azithromycin salt |
| 08/02/2006 | CN1810249A Soft medicine composition capsule and its prepn |
| 08/02/2006 | CN1810248A Application of compound vitamins in preparing medicine for treating tuberculosis |
| 08/02/2006 | CN1810240A Prepn process and use of total andrographolide emulsion |
| 08/02/2006 | CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267553C Haemophilus transferrin receptor genes |
| 08/02/2006 | CN1267552C Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 08/02/2006 | CN1267551C Expression of recombinant mature lysostaphin |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 08/02/2006 | CN1267443C Cyclic lactone antibiotic intermediate and its preparation |
| 08/02/2006 | CN1267442C Process for preparation of 12-dehydroxy azithromycin |
| 08/02/2006 | CN1267436C Process for synthesizing cefpirome sulfate |
| 08/02/2006 | CN1267421C Antiviral activity possessed compound |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267153C A and O type gene engineering bivalent polypeptide vaccine of livestock foot-and-mouth disease virus and its preparation process |
| 08/02/2006 | CN1267152C Polythylene glycol-interferon alpha foreeze dried preparation |
| 08/02/2006 | CN1267147C Effervescence tablet of antiviral medicine and its preparation process |
| 08/02/2006 | CN1267120C Frozen dry powder injection of houttuynia cordata and its preparation |
| 08/02/2006 | CN1267110C Elsholizia and naphtha pharmacy preparation use |
| 08/02/2006 | CN1267109C Preparation method of achillea effective part medicinal preparation |
| 08/02/2006 | CN1267105C Broad spectrum bacteriostat and sterilizing of silicate based angstrom silver ion nano porous composite mateiral |
| 08/02/2006 | CN1267102C Composition with anti-virus function and its preparing process |
| 08/02/2006 | CN1267101C Citron acid Azithromycin frozen-dried preparation for injection and preparation method thereof |
| 08/02/2006 | CN1267100C Medicinal composition and its preparation and use |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 08/02/2006 | CN1267091C Anti-influenza agent |
| 08/02/2006 | CN1267090C Garlicin injection emulsion and its preparing method |
| 08/02/2006 | CN1267087C Pharmaceutical tablet |
| 08/01/2006 | US7084268 producing (+)-(1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-pyrrolidine-3-yl-(R)-hydroxymethyl]pyrrolidine-4-yl]thio-1-carbapen-2-em-3-carboxylic acid monohydrochloride trihydrate crystals |
| 08/01/2006 | US7084261 formed by reacting a polypeptide with a capped N-(formylalkyl)polyoxyalkylenealkamide, used for inhibiting HIV infection |
| 08/01/2006 | US7084240 Crystallization of IGF-1 |
| 08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083814 Antiviral substances from plant cuticular and epicuticular material |
| 08/01/2006 | US7083796 Fusion proteins of mycobacterium tuberculosis |
| 08/01/2006 | US7083795 Inactivated respiratory syncytial viral vaccines |